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ABSTRACT
Human fascioliasis is a zoonotic disease caused by two parasites of class Trematoda, namely Fasciola hepatica and F. gigantica. It is 
prevalent, particularly in regions with farming communities having sheep or cattle. In India, cases are not frequently reported despite 
being one of the dominant countries in livestock production. Usually, humans are incidental hosts that acquire infection by ingesting 
contaminated aquatic vegetation or water. If not diagnosed timely, it can lead to fatal complications.The authors report a case of 
hepatobiliary fascioliasis in a female presented with non-specific complaints. A thorough investigation including parasitological 
evaluation helped to reach the diagnosis. This case highlights the importance of awareness, diagnosis and appropriate treatment of 
fascioliasis with Triclabendazole for complete cure.
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Human fascioliasis is a global disease and reported from more than 75 countries worldwide. Since no reported deaths are associated with fascioliasis, it is ranked as a 
neglected tropical disease (NTD) [1]. Patients usually complaints 
of irregular fever, eosinophilia, and abdominal pain but the clinical 
presentation can vary from mild to severe in nature [2]. Even 
asymptomatic cases are relatively frequentin endemic rural areas.
This infection is treatable with a single dose of Triclabendazole as 
recommended by the World Health Organization (WHO) because 
failures are noted with drugs like Praziquantel or Nitazoxanide. 
Preventive measures should be considered which include 
education on the mode of transmission and boiling or drying 
fresh watercress before eating [3]. In a country like India, where 
availability of advanced diagnostic modality is a limitation, 
diagnosis is always based on microscopic examination of stool or 
duodenal content or bile. 
Few case reports and incidental findings have been reported 
from India but epidemiological data on the prevalence is not 
available because of difficulty in the identification of cases and 
lack of awareness. We report a case of hepatobiliary fascioliasis 
in a female patient with an uncommon presentation. A high index 
of suspicion along with diagnostic workup is warranted forthe 
successful outcome of the patient.
CASE REPORT
A 54-year-old female presented with complaints of multiple 
episodes of non-bilious, intractable vomiting associated with 
vertigo for six days. Pain in upper right quadrant which was 
intermittent and extreme in nature, generalised myalgia and fever 
on & off low-grade for eight days. History of headache, icterus 
or hematemesis was ruled out. The patient had a past history of 
the liver abscess five years ago which was treated and resolved. 
The patient gave a history of travelling to Rajasthan a few months 
back.
At the time of admission, there were no significant findingson 
systemic examination. On physical examination, the patient was 
febrile with pulse rate 88/min and 18 breaths /min respiratory rate. 
The patient had raised liver function tests: bilirubin 4.2 mg/
dl, serum glutamic oxaloacetic transaminase (SGOT) 101 U/L 
Figure 1: Macroscopic image of the specimen submitted for 
examination.
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and serum glutamic pyruvic transaminase (SGPT) 229 U/L. 
Hemogram showed 78% neutrophils, 12% lymphocytes and 0 
eosinophils. Ultrasonogram (USG) of the abdomen revealed 
dilated common bile duct along with a thin linear irregular 
structure within gall bladder and distal common bile duct which 
suggested further investigation. Later on, magnetic resonance 
cholangiopancreatography (MRCP) was done that showed 
dilated biliary tract with irregular filling defects. In view of that, 
endoscopic retrograde cholangiopancreatography (ERCP) was 
advised for sphincterotomy. During the procedure, flat leaf-like 
moving structure was observed accidentally in the common bile 
duct, which was removed and sent to the microbiology laboratory 
for further identification. 
On macroscopic examination, the specimen was flat, leaf-
like with an approximate size of 28 mm X 13 mm and brown 
to brick red in colour (Fig. 1). The anterior end had cone-
shaped projection while the posterior end was broadly pointed. 
Two suckers were present: one at the extreme anterior end and 
ventral sucker immediately posterior to the darkly pigmented 
structure of the organism (Fig. 2). Based on the characteristic 
morphological appearance, an adult worm of F. hepatica was 
suspected. The captured images of the worm were sent to Centre 
for Disease Control and prevention (CDC), Atlanta, USA for 
the identification and it was confirmed as an adult worm of F. 
hepatica. The patient’s stool specimen was asked for microscopic 
examination but the wet mount didn’t show ova.
The patient was started on Albendazole (10mg/kg/day) and 
Ivermectin (200µg/kg/day) for 7 days. Soon after the diagnosis, 
a single dose of Triclabendazole was advised and the drugs were 
changed. Prednisolone at a dose of 10-20mg/day was given 
to prevent an immunological reaction against toxic products 
released by dead worms in the body. The patient was discharged 
after 5 days of observation and lost for follow-up.
DISCUSSION
Fascioliasis is one of the significant parasitic infections known 
to cause biliary tract inflammation and obstruction. Symptoms 
may vary but commonest are fever, biliary colic with vomiting, 
malaise, persistent diarrhoea, anorexia, weight loss and peripheral 
eosinophilia [4]. Till date, a few case reports and incidental 
findings were reported on the basis of imaging or endoscopy from 
India [5,6,7]. The low prevalence may be due to the lack of basic 
knowledge and practices of such parasitic infections.
Humans are incidental hosts that acquire infection by ingestion 
of aquatic vegetations like watercress or by drinking water. 
This parasite completes its life cycle in two different hosts. The 
definitive hosts are sheep, goat, cattle or man and intermediate 
hosts are snails. Adult worms that reside in biliary passage pass 
eggs in feces which in water develop into a ciliated miracidium. 
The miracidium passes through different stages of sporocyst in 
the intermediate host. The mature cercariae are released from the 
snails after aperiod of 30-60 days and get settled in water or over 
vegetation. This encysted cercariae gets access to definitive hosts 
through ingestion. In the duodenum, excystation occurs and motile 
parasitic form migratesfrom the intestinal wall, traverse through 
the peritoneal cavity and get settle in the biliary passage. Within 
a month, cercariae transform into adult forms and start releasing 
eggs. The eggs are passed in the feces through the bile in about 
3–4 months after infection and the cycle is then repeated [8].
During the migration of the mature cercariae, they cause 
extensive damage to the liver tissue by mechanical irritation 
as well as by their toxic secretion. Based onthe pathological 
changes in the biliary tract, hepatobiliary infection is divided into 
two distinct phases: an acute hepatic phasewhich is clinically 
manifested by the upper abdominal pain, fever, hepatomegaly, 
intense eosinophilia and the chronic biliary phase where the adult 
worm causes periodic biliary obstruction. Intense peripheral 
eosinophilia is noted in both phases of infectionbutmany cases have 
been reported in which eosinophilia was absent [9]. Furthermore, 
in endemic areas of developing countries, eosinophilia may also 
be caused by other helminthic infections and local food habits.
The causative agent of fascioliasis could be F. hepatica or F. 
gigantica. The size and shape of the eggs is a crucial diagnostic 
feature because both species can co-existand they have different 
transmission and epidemiological characteristics.Valero et al 
[10] had suggested the differentiation of species by applying the 
size ranges. F. gigantic doubles the size of F. hepatica and the 
posterior end of the F. hepatica is pointed, whereas, F. gigantica 
is rounded. However, molecular methods at the gene level are 
required for further confirmation of species.
Microscopic examination of stool is one of the easiest diagnostic 
methods but multiple specimens needed to be examined because of 
intermittent shedding of eggs. Specific tests are required because 
negative fecal specimens do not exclude the diagnosis [11]. 
Serology is useful in the early detection prior to the appearance 
of eggs in thefeces. Even declining antibody titers correlate with 
successful treatment but antibodies persist for years after infection 
[12]. So, serological diagnosis could be debatable. Demerdash 
et al [13] showed sensitivity and specificity of 96% and 98.2% 
in the stool while 94% and 94.6% in the serum respectively as 
detected through Enzyme-linked immunosorbent assay (ELISA). 
Radiological features in endemic regions are helpful too for 
diagnosis. Some findings observed in biliary phase are biliary wall 
thickening, echogenic worm casts, and intrahepatic biliary radicle 
dilatation. ERCP may be normal in early disease and mimics 
closely primary sclerosing cholangitis in the chronic phase.
For treatment, the WHO recommends a single dose of 
Triclabendazole 10mg/kg body weight for a complete cure. 
Figure 2: Parasite with two suckers: extreme anterior and ventral 
sucker.
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Nitazoxanide found to be well tolerated with a cure rate of 40% 
and 60% in children and adults, respectively [14]. Treatment failures 
are common with Praziquantel; therefore, it is not recommended. 
Preventive measures, which include information, education and 
communication on the mode of transmission, are effective too. Public 
health measures and environmental measures such as containment 
of the intermediate host and drainage of grazing lands in endemic 
areas are recommended. Family members of the patient should also 
be screened for the infection as they may harbor the parasite with 
or without symptoms since they share the common food and water.
Fascioliasis has a patchy distribution worldwide, with foci 
related to the local distribution of intermediate host population 
and farming. Hybrid species have been reported in regions 
with a geographical overlap of two species [15]. In India, the 
geographical distribution of species is not clearly documented. 
Till date, cases of human fascioliasis have been reported from the 
north and northeastern India including Assam, UP and Bihar. So, 
the patient with supporting clinical history should be suspected 
of fascioliasis. Stool routine microscopy examination and their 
treatment is simply a short course of anti-helminthic therapy. 
CONCLUSION
Although not well-documented in India, ahigh index of suspicion 
for diagnosis is warranted in patients presented with abdominal 
pain, hepatomegaly and focal lesions in the liver with or without 
eosinophilia. The occurrence of this disease in India could be 
greater than previously reported.Once diagnosed, should be 
treated with a single dose of Triclabendazole for a complete cure.
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